The Application of Nanotechnology for the Diagnosis and Treatment of Brain Diseases and Disorders.
Ebenezeri Erasto Ngowi,Ebenezeri Erasto Ngowi,Yi-Zhen Wang,Lei Qian,Yasmeen Ahmed Saleheldin Hassan Helmy,Bright Anyomi,Tao Li,Meng Zheng,En-She Jiang,Shaofeng Duan,Jian-She Wei,Dongdong Wu,Xin-Ying Ji +12 more
TLDR
In this article, the authors focus on the application of nanotechnology in the diagnosis and treatment of brain diseases and disorders by illuminating the potential of nanoparticles, which has proven to be useful in diagnosis as well as treatments of brain disease and disorders.Abstract:
Brain is by far the most complex organ in the body. It is involved in the regulation of cognitive, behavioral, and emotional activities. The organ is also a target for many diseases and disorders ranging from injuries to cancers and neurodegenerative diseases. Brain diseases are the main causes of disability and one of the leading causes of deaths. Several drugs that have shown potential in improving brain structure and functioning in animal models face many challenges including the delivery, specificity, and toxicity. For many years, researchers have been facing challenge of developing drugs that can cross the physical (blood-brain barrier), electrical, and chemical barriers of the brain and target the desired region with few adverse events. In recent years, nanotechnology emerged as an important technique for modifying and manipulating different objects at the molecular level to obtain desired features. The technique has proven to be useful in diagnosis as well as treatments of brain diseases and disorders by facilitating the delivery of drugs and improving their efficacy. As the subject is still hot, and new research findings are emerging, it is clear that nanotechnology could upgrade health care systems by providing easy and highly efficient diagnostic and treatment methods. In this review, we will focus on the application of nanotechnology in the diagnosis and treatment of brain diseases and disorders by illuminating the potential of nanoparticles.read more
Citations
More filters
Journal ArticleDOI
Benefits and limitations of nanomedicine treatment of brain cancers and age-dependent neurodegenerative disorders.
TL;DR: In this paper , the authors discuss effective nanomedicine approaches designed to overcome the current limitations in the therapy of brain cancers and age-dependent neurodegenerative disorders, and discuss the perspectives and limitations of nanodrug use associated with the specificity of nervous tissue characteristics and the effects nanocarriers have on cognition.
Journal ArticleDOI
The Role of Graphene Oxide Nanocarriers in Treating Gliomas
TL;DR: Research on GO nanocarriers in the treatment of gliomas in recent years is reviewed and also new ideas for thetreatment of these tumors are highlighted.
Journal ArticleDOI
Application of Metal-Based Nanozymes in Inflammatory Disease: A Review
TL;DR: This review summarizes the application of some representative metal-based nanozymes in inflammatory diseases and discusses theApplication of various novel nanomaterials for different therapies and the prospects of using nanoparticles (NPs) as biomedical materials.
Journal ArticleDOI
Impact of nanoparticles on amyloid β-induced Alzheimer’s disease, tuberculosis, leprosy and cancer: a systematic review
TL;DR: In this paper , the application of different nanoparticles for the treatment of these four important diseases (Alzheimer's disease, tuberculosis, leprosy and cancer) as well as for the effective delivery of drugs used in these diseases used in biomedical field.
Journal ArticleDOI
The Emerging Applications of Nanotechnology in Neuroimaging: A Comprehensive Review
TL;DR: The use of different types of nanotechnology to improve the detection, diagnosis, and treatment of a wide range of neurological diseases is discussed.
References
More filters
Journal ArticleDOI
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray,Jacques Ferlay,Isabelle Soerjomataram,Rebecca L. Siegel,Lindsey A. Torre,Ahmedin Jemal +5 more
TL;DR: A status report on the global burden of cancer worldwide using the GLOBOCAN 2018 estimates of cancer incidence and mortality produced by the International Agency for Research on Cancer, with a focus on geographic variability across 20 world regions.
Journal ArticleDOI
Alpha-synuclein in Lewy bodies.
Maria Grazia Spillantini,Marie L. Schmidt,Virginia M.-Y. Lee,John Q. Trojanowski,Ross Jakes,Michel Goedert +5 more
TL;DR: Strong staining of Lewy bodies from idiopathic Parkinson's disease with antibodies for α-synuclein, a presynaptic protein of unknown function which is mutated in some familial cases of the disease, indicates that the LewY bodies from these two diseases may have identical compositions.
Journal ArticleDOI
Heart Disease and Stroke Statistics—2020 Update: A Report From the American Heart Association
Salim S. Virani,Alvaro Alonso,Emelia J. Benjamin,Márcio Sommer Bittencourt,Clifton W. Callaway,April P. Carson,Alanna M. Chamberlain,Alex R. Chang,Susan Cheng,Francesca N. Delling,Luc Djoussé,Mitchell S.V. Elkind,Jane F. Ferguson,Myriam Fornage,Sadiya S. Khan,Brett M. Kissela,Kristen L. Knutson,Tak W. Kwan,Daniel T. Lackland,Tené T. Lewis,Judith H. Lichtman,Chris T. Longenecker,Matthew Shane Loop,Pamela L. Lutsey,Seth S. Martin,Kunihiro Matsushita,Andrew E. Moran,Michael E. Mussolino,Amanda M. Perak,Wayne D. Rosamond,Gregory A. Roth,Uchechukwu K.A. Sampson,Gary Satou,Emily B. Schroeder,Svati H. Shah,Christina M. Shay,Nicole L. Spartano,Andrew Stokes,David L. Tirschwell,Lisa B. VanWagner,Connie W. Tsao +40 more
TL;DR: This year's edition of the Statistical Update includes data on the monitoring and benefits of cardiovascular health in the population, metrics to assess and monitor healthy diets, an enhanced focus on social determinants of health, a focus on the global burden of cardiovascular disease, and further evidence-based approaches to changing behaviors, implementation strategies, and implications of the American Heart Association’s 2020 Impact Goals.
Journal ArticleDOI
2016 Alzheimer's disease facts and figures
Journal ArticleDOI
Prevalence of Autism Spectrum Disorder Among Children Aged 8 Years — Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2014
Jon Baio,Lisa D. Wiggins,Deborah Christensen,Matthew J. Maenner,Julie L. Daniels,Zachary Warren,Margaret Kurzius-Spencer,Walter Zahorodny,Cordelia Robinson Rosenberg,Tiffany White,Maureen S. Durkin,Pamela Imm,Loizos Nikolaou,Loizos Nikolaou,Marshalyn Yeargin-Allsopp,Li-Ching Lee,Rebecca A. Harrington,Maya Lopez,Robert T. Fitzgerald,P Amy Hewitt,Sydney Pettygrove,John N. Constantino,Alison Vehorn,Josephine Shenouda,Jennifer Hall-Lande,Kim Van Naarden Braun,Nicole F. Dowling +26 more
TL;DR: This report provides updated ASD prevalence estimates for children aged 8 years during the 2014 surveillance year, on the basis of DSM-IV-TR criteria, and describes characteristics of the population of children with ASD.